Severe comorbid infections in patients with inflammatory joint diseases: frequency, structure, risk factors

Severe comorbid infections (SCI) are infections that develop against the background of the underlying disease and require hospitalization and/or intravenous administration of antibacterial drugs. In the structure of comorbid infections in patients with inflammatory joint diseases (IJD), the number of SCI does not exceed 4%. However, they are the direct cause of death in these patients. Various factors, including sociodemographic factors, as well as factors directly related to the IJD itself, including therapy, contribute to the development of SCI. This article discusses the incidence, structure and risk factors in patients with IJD.

Authors

Publication Details

Journal
Modern Rheumatology Journal
Published
2025-04-22
DOI
https://doi.org/10.14412/1996-7012-2025-2-107-112
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Severe comorbid infections in patients with inflammatory joint diseases: frequency, structure, risk factors

N. V. Muravyevа, Б. С. Белов, М. М. Баранова
Modern Rheumatology Journal
Rheumatoid Arthritis Research and Therapies
article

Severe comorbid infections in patients with inflammatory joint diseases: frequency, structure, risk factors

N. V. Muravyevа, Б. С. Белов, М. М. Баранова
article en

Abstract

Severe comorbid infections (SCI) are infections that develop against the background of the underlying disease and require hospitalization and/or intravenous administration of antibacterial drugs. In the structure of comorbid infections in patients with inflammatory joint diseases (IJD), the number of SCI does not exceed 4%. However, they are the direct cause of death in these patients. Various factors, including sociodemographic factors, as well as factors directly related to the IJD itself, including therapy, contribute to the development of SCI. This article discusses the incidence, structure and risk factors in patients with IJD.

Modern Rheumatology JournalVol. 19(2)
Openalex Percentile: Top 87%
Rheumatoid Arthritis Research and Therapies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.